Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
24,448,605
-
Share change
-
+1,684,627
-
Total reported value
-
$146,690,354
-
Put/Call ratio
-
1.6%
-
Price per share
-
$6.00
-
Number of holders
-
37
-
Value change
-
+$10,585,699
-
Number of buys
-
20
-
Number of sells
-
16
Institutional Holders of SATSUMA PHARMACEUTICALS INC - COM (STSA) as of Q3 2022
As of 30 Sep 2022 SATSUMA PHARMACEUTICALS INC - COM (STSA) had 37 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 24,448,605 shares of stock of the company.
Largest 10 holders included RA CAPITAL MANAGEMENT, L.P., COMMODORE CAPITAL LP, NEA Management Company, LLC, SAMLYN CAPITAL, LLC, TPG GP A, LLC, DRIEHAUS CAPITAL MANAGEMENT LLC, Vivo Capital, LLC, VANGUARD GROUP INC, AMERIPRISE FINANCIAL INC, and DIMENSIONAL FUND ADVISORS LP.
This table shows 37 institutional shareholders of the security as of 30 Sep 2022.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.